ViewRay, Inc.
Healthcare · Electromedical & Electrotherapeutic Apparatus · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $102.2M | $70.1M | $57.0M | $87.8M | $81.0M | $34.0M |
| Operating income | −$107.1M | −$103.6M | −$106.0M | −$120.8M | −$75.1M | −$48.2M |
| Net income | −$107.3M | −$110.0M | −$107.9M | −$120.2M | −$76.4M | −$72.2M |
| Total assets | $271.4M | $321.8M | $261.6M | $350.0M | $295.0M | $135.7M |
| Total liabilities | $189.2M | $152.0M | $131.3M | $133.8M | $127.7M | $133.7M |
| Equity | $82.2M | $169.8M | $130.3M | $216.2M | $167.3M | $2.0M |
| EPS (diluted) | $-0.59 | $-0.67 | $-0.73 | $-1.18 | — | — |
| Shares out. | 179.4M | 160.8M | 147.4M | 96.7M | 67.7M | 55.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −104.8%
- Net margin
- −105.0%
- Return on equity
- −130.5%
- Return on assets
- −39.5%
- Return on capital (ROCE)
- −61.3%
- Liabilities / assets
- 69.7%
- Debt / equity
- 2.30×
- Book value / share
- $0.46
- Revenue growth (YoY)
- 45.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -9.15distress
- Accruals / assets
- −5.8%clean
- Beneish M-Score
- -2.42normal
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 14, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Shah SanketOfficer — SVP, General Counsel | Jul 15, 2023 | Grant | 350,000 | $0.00 |
| Podbelski Adam AndrewOfficer — SVP, Customer Services | Jul 15, 2023 | Grant | 350,000 | $0.00 |
| Johnson B KristineDirector | Jul 21, 2023 | Sell | 30,702 | $0.05 |
| Ebrahimi Farhad Fred10% owner | Jul 17, 2023 | Option exercise | 455,300 | $1.50 |
| Castelein CaleyDirector | Jul 19, 2023 | Sell | 158,397 | $0.07 |
| Ziegler Paul JrOfficer — Chief Executive Officer | Jul 19, 2023 | Sell | 169,785 | $0.07 |
| Prange KarenDirector | Jul 19, 2023 | Sell | 91,866 | $0.07 |
| Johnson B KristineDirector | Jul 18, 2023 | Sell | 79,622 | $0.07 |
| Drake Scott WilliamDirector | Jul 18, 2023 | Sell | 2.4M | $0.06 |
| Ziegler Paul JrOfficer — Chief Executive Officer | Jul 15, 2023 | Grant | 1.2M | $0.00 |
| Ebrahimi Farhad Fred10% owner | Jul 5, 2023 | Option exercise | 13,600 | $1.50 |
| Ebrahimi Farhad Fred10% owner | Jun 28, 2023 | Option exercise | 20,700 | $4.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Regulation FD disclosureSep 7, 2023
- Other material eventAug 3, 2023
- Delisting / listing-standard notice · Regulation FD disclosureJul 21, 2023
- Entered a material agreement · Bankruptcy or receivership · Debt acceleration / triggering event · Director / officer change · Regulation FD disclosureJul 17, 2023
- Director / officer changeJul 7, 2023
- Delisting / listing-standard noticeJun 30, 2023
- Results of operations · Regulation FD disclosureMay 10, 2023
- Results of operations · Regulation FD disclosureApr 13, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.